Brief: Samsung Pharmaceutical to issue 28th series convertible bonds worth 10.2 bln won

Samsung Pharm

06/02/2017 08:26

Feb 6 (Reuters) - Samsung Pharmaceutical Co Ltd  001360.KS  
: 
    
    * Says it will issue 28th series unregistered and unsecured 
private convertible bonds to raise 10.2 billion won in proceeds 
for operations 
    * Says maturity date is Feb. 6, 2020, coupon rate is 0 
percent and yield to maturity is 4 percent for the bonds 
    * Conversion price is 4,102 won/share and conversion ratio 
is 100 percent  
     
     
    Source text in Korean: https://goo.gl/iCQoy4 
    Further company coverage:  001360.KS  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: hedy.cui.reuters.com@reuters.net))